Tag Archives: biomarkers

BIO’s Prometheus v. Mayo Amicus Brief Filed

prometheus

BIO filed an amicus brief in the Prometheus v. Mayo Clinic case.  In this case the Supreme Court is being asked to decide whether diagnostic and personalized medicine claims that depend on a correlation of observed phenomena should be excluded from the patent system at the outset, as patent-ineligible abstract ideas or “laws of nature.” BIO’s brief argues that these judicially-created exclusions from patent-eligibility have traditionally been used only under narrow circumstances, and that their Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

oncology

Insights in to the molecular and genetic basis of disease are driving new product and therapeutic opportunities while changing the treatment paradigm for many cancers. The use of companion diagnostics in oncology may play a role in optimizing and expediting the development of targeted therapies for many cancers and other conditions. Focusing on these new markets, a panel of industry executives and investors at the 2011 BIO Investor Forum discussed some of the most compelling Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Applying A Holistic Approach to Solve a Complex Disease

coetzee

By Dr. Timothy Coetzee, Chief Research Officer at the National MS Society Multiple sclerosis (MS) is a complex disease involving immune-system attacks on the central nervous system. Research into MS involves questions that dovetail many fields of science, including immunology, neuroscience, psychology and more.   Promoting and funding collaborative research is one piece of the puzzle, receiving a great deal of media attention of late.   However, it is even more important to apply a multi-faceted, rather Read More >

Health  |  4 Comments  |  Email This Post
Tags: , , , , ,